Bioactive extracellular vesicles from a subset of endothelial progenitor cells rescue retinal ischemia and neurodegeneration

Disruption of the neurovascular unit (NVU) underlies the pathophysiology of various CNS diseases. One strategy to repair NVU dysfunction uses stem/progenitor cells to provide trophic support to the NVU's functionally coupled and interdependent vasculature and surrounding CNS parenchyma. A subset of endothelial progenitor cells, endothelial colony-forming cells (ECFCs) with high expression of the CD44 hyaluronan receptor (CD44(h)(i)), provides such neurovasculotrophic support via a paracrine mechanism. Here, we report that bioactive extracellular vesicles from CD44(h)(i) ECFCs (EVs(hi)) are paracrine mediators, recapitulating the effects of intact cell therapy in murine models of ischemic/neurodegenerative retinopathy; vesicles from ECFCs with low expression levels of CD44 (EVs(lo)) were ineffective. Small RNA sequencing comparing the microRNA cargo from EVs(hi) and EVs(lo) identified candidate microRNAs that contribute to these effects. EVs(hi) may be used to repair NVU dysfunction through multiple mechanisms to stabilize hypoxic vasculature, promote vascular growth, and support neural cells.

Automated summary

The study found that bioactive extracellular vesicles from endothelial colony-forming cells (ECFCs) with high expression of CD44 have neurovasculotrophic effects, and may repair dysfunction of the neurovascular unit (NVU) through multiple mechanisms.